CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia

Povorcitinib, a selective oral JAK1 inhibitor discovered by Incyte, is an investigational medicine being evaluated for the treatment of non-segmental vitiligo, hidradenitis suppurativa (HS), prurigo nodularis (PN), asthma and chronic …

CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia Read More

Grid Battery Renews Engagement with Triomphe Holdings Ltd. (DBA Capital Analytica) To Provide Social Media Services

(via TheNewswire) Coquitlam, BC / TheNewswire / March 7, 2024- Grid Battery Metals Inc. (the “Company” or “Grid”) (TSXV:CELL) (OTC:EVKRF) (FRA:NMK2) announces that it has renewed its contract with Triomphe …

Grid Battery Renews Engagement with Triomphe Holdings Ltd. (DBA Capital Analytica) To Provide Social Media Services Read More